Brought to you by 
Stryker acquires Orthovita for $309mm in cash and debt
18 May 2011
Executive Summary
In what is said to be the largest-ever up-front fee for an orthobiologics firm, orthopedic device giant Stryker Corp. is buying Orthovita Inc. for $3.85 per share in cash (a 50% premium) plus $12mm in debt, valuing the deal at about $309mm.
Deal Industry
- Biotechnology
- Medical Devices
-
Medical Devices
- Biomaterials
- Implantable Devices
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Stryker acquires Orthovita for $309mm in cash and debt
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice